✦ LIBER ✦

82* Microbiological and clinical response to tobramycin inhalation powder (TIP(tm)) in cystic fibrosis patients with chronic Pseudomonas aeruginosa (Pa) infection

✍ Scribed by D.E. Geller; P.A. Flume; M. Konstan; G. Angyalosi; M. Higgins

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of tobramycin inhala

✍ M. Konstan; P.A. Flume; F. Brockhaus; G. Angyalosi; E. He; D. Geller 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

110 Head-to-head comparison of two inhal

✍ H. Mazurek; G. Lenoir; L. Pelikan; C. Geidel; K. Bolbas; Y. Antipkin; M.A. Blanc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

66 Efficacy of tobramycin inhalation pow

✍ M.-M. Balp; G. Capkun-Niggli; K. Littlewood; G. Doring; G. Angyalosi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Direct comparison of in vitro susceptibi

✍ John E. Moore; Yasunori Maeda; Colin E. Goldsmith; Jacqueline C. Rendall; J. Stu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 112 KB

WS5.5 A randomised, open label phase 3 s

✍ M. Goldman; A. Schuster; C. Halliburn; G. Döring 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

107 In vitro susceptibility of Pseudomon

✍ T. Pressler; B.M. Assael; R. Fischer; M. Bresnik; S. Lewis; M. McKevitt; A.B. Mo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB